Multi-Modal Pathology-Radiology Fusion Market Report 2026

Multi-Modal Pathology-Radiology Fusion Market Overview

• Multi-Modal Pathology-Radiology Fusion market size has reached to $1.87 billion in 2025 • Expected to grow to $3.63 billion in 2030 at a compound annual growth rate (CAGR) of 14.3% • Growth Driver: The Rise In Demand For Personalized Medicine Driving The Growth Of The Market Due To Rising Prevalence Of Chronic And Complex Diseases • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Multi-Modal Pathology-Radiology Fusion Market?

Multi-modal pathology-radiology fusion refers to the integration of pathological and radiological data using advanced computational techniques to provide a comprehensive view of a patient’s disease at both the tissue and imaging levels. This approach enables more accurate diagnosis, prognosis, and treatment planning by combining microscopic cellular information from pathology with macroscopic imaging insights from radiology. The main components of the multi-modal pathology-radiology fusion market include software, hardware, and services. Software refers to platforms and tools that integrate and analyze data from multiple imaging modalities and pathology sources to support diagnosis, treatment planning, and clinical decision-making. The modalities covered include computed tomography, magnetic resonance imaging, positron emission tomography, ultrasound, X-ray, digital pathology, and other modalities and are deployed through on-premises and cloud-based modes. The applications include oncology, neurology, cardiology, orthopedics, and other applications and caters to end-users include hospitals, diagnostic centers, research institutes, and others.

What Is The Multi-Modal Pathology-Radiology Fusion Market Growth Forecast?

The multi-modal pathology-radiology fusion market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to growing demand for personalized treatment planning, increasing integration of multi-modal diagnostic platforms, rising investment in cloud-based healthcare infrastructure, expanding applications in oncology and neurology, growing collaboration between hospitals and research institutes. Major trends in the forecast period include increasing adoption of integrated diagnostic software platforms, rising demand for image registration and 3d reconstruction tools, growing use of telepathology and teleradiology services, expansion of workflow integration and clinical decision support services, rising investment in advanced medical imaging hardware.

Global Multi-Modal Pathology-Radiology Fusion Market Segmentation

1) By Component: Software, Hardware, Services 2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, X-ray, Digital Pathology, Other Modalities 3) By Deployment Mode: On-Premises, Cloud-Based 4) By Application: Oncology, Neurology, Cardiology, Orthopedics, Other Applications 5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Other End-Users Subsegments: 1) By Hardware: Robot Arms and Manipulators, Collaborative Robots (Cobots), End-Effectors and Grippers, Sensors and Perception Hardware, Actuators and Drives, Machine Vision Systems, Controllers and PLCs, Automated Guided Vehicle And Autonomous Mobile Robot, Safety Systems and Fencing, Power and Cabling Infrastructure 2) By Software: Robot Operating Systems and Firmware, Simulation and Digital-Twin Software, Motion Planning and Path Optimization, Artificial Intelligence and Machine Learning Software, Vision and Perception Software, Cell and Fleet Management Software, MES or ERP Integration Software, Predictive Maintenance and Analytics, Cybersecurity Software, Low-Code or No-Code Programming Tools 3) By Services: System Design and Engineering, Integration and Commissioning, Maintenance and Field Support, Training and Skill Development, Retrofit and Modernization Services, Custom Application Development, Robotics-as-a-Service (RaaS), Validation and Testing Services, Consulting and ROI Analysis, R&D and Co-innovation Services

What Is The Driver Of The Multi-Modal Pathology-Radiology Fusion Market?

The increasing demand for personalized medicine is expected to propel the growth of the multi-modal pathology-radiology fusion market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, treatments, and interventions to the individual characteristics of each patient, such as their genetic profile, lifestyle, and environment. The increasing demand for personalized medicine is primarily driven by the rising prevalence of chronic and complex diseases, as tailored treatments can more effectively target individual patient needs and improve outcomes. Multi-modal pathology-radiology fusion supports personalized medicine by integrating cellular-level pathological insights with comprehensive imaging data, enabling precise disease characterization, optimized treatment planning, and improved prediction of patient-specific therapeutic responses. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the multi-modal pathology-radiology fusion industry. The Growing Implementation Of Electronic Health Records The Growth Of The Market Due To Need For Operational Efficiency The growing implementation of electronic health records (EHRs) is expected to propel the growth of the multi-modal pathology-radiology fusion market. EHRs are digital versions of patients’ medical histories, including diagnoses, treatments, medications, and test results, designed to be securely shared across healthcare providers to improve care coordination and clinical outcomes. The increasing adoption of EHRs is driven by factors such as the need for operational efficiency, regulatory mandates, and improved clinical decision-making. EHR implementation supports multi-modal pathology-radiology fusion by providing an interoperable, patient-centered digital infrastructure that enables the integration and correlation of imaging, pathology, and clinical data for informed diagnostic and treatment decisions. For instance, in March 2024,according to the Department of Health and Social Care, a UK-based government department, by March 2025, all NHS trusts are expected to have adopted electronic health records, an increase from 90% that had implemented them by December 2023. Therefore, the growing implementation of electronic health records is driving the growth of the multi-modal pathology-radiology fusion industry. Growing Investment In Healthcare Information Technology Driving The Growth Of The Market Due To Enhanced Data Integration And Precision In Patient Care The growing investment in healthcare information technology infrastructure is expected to propel the growth of the multi-modal pathology-radiology fusion market going forward. Investment in healthcare information technology infrastructure refers to the allocation of financial and organizational resources toward developing, implementing, and maintaining digital systems and technologies that enhance the collection, storage, management, and sharing of healthcare data. Growing investment in healthcare information technology infrastructure is primarily driven by the rising demand for digital health solutions, as healthcare providers seek to enhance patient care, streamline operations, and enable remote monitoring through advanced technologies. Investment in healthcare information technology infrastructure enables seamless integration, storage, and analysis of diverse clinical data, thereby accelerating multi-modal pathology-radiology fusion and enhancing precision in diagnosis and personalized treatment. For instance, in January 2024, according to the Kaplan Business School (KBS), an Australia-based higher education provider, from 2023 to 2024, the Australian Government increased healthcare spending to $137.6 billion, up from a record $106 billion in 2022–2023, aiming to enhance healthcare services nationwide. Therefore, the growing investment in healthcare information technology infrastructure is driving the growth of the multi-modal pathology-radiology fusion industry.

Key Players In The Global Multi-Modal Pathology-Radiology Fusion Market

Major companies operating in the multi-modal pathology-radiology fusion market are Google Health LLC, NVIDIA Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., FUJIFILM Healthcare Americas Corporation, IMERIT Inc., Barco N.V., Agfa HealthCare N.V., Tempus AI Inc., Aidoc Medical Ltd., Owkin Inc., Lunit Inc., PAIGE.AI Ltd., Proscia Inc., Canon Medical Systems Corporation, Imagene AI Ltd., Techcyte Inc., Mindpeak GmbH, and Akira AI Inc.

nan

nan

Regional Insights

North America was the largest region in the multi-modal pathology-radiology fusion market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Multi-Modal Pathology-Radiology Fusion Market?

The multi-modal pathology-radiology fusion market consists of revenues earned by entities by providing services such as diagnostic imaging analysis, digital pathology services, clinical decision support services, consulting and workflow integration, and telepathology and teleradiology services. The market value includes the value of related goods sold by the service provider or included within the service offering. The multi-modal pathology-radiology fusion market also includes sales of fusion and integrated diagnostic software platforms, digital pathology systems and software, medical imaging hardware, cloud‑based fusion and collaboration platforms, image registration and 3d reconstruction tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Multi-Modal Pathology-Radiology Fusion Market Report 2026?

The multi-modal pathology-radiology fusion market research report is one of a series of new reports from The Business Research Company that provides multi-modal pathology-radiology fusion market statistics, including multi-modal pathology-radiology fusion industry global market size, regional shares, competitors with a multi-modal pathology-radiology fusion market share, detailed multi-modal pathology-radiology fusion market segments, market trends and opportunities, and any further data you may need to thrive in the multi-modal pathology-radiology fusion industry. This multi-modal pathology-radiology fusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.